Thomas F. Gajewski
Keine laufenden Positionen mehr
Profil
Thomas F.
Gajewski is the founder of Jounce Therapeutics, Inc. (founded in 2013).
Dr. Gajewski is also the founder of Pyxis Oncology, Inc. He received his undergraduate and doctorate degrees from The University of Chicago.
Ehemalige bekannte Positionen von Thomas F. Gajewski
| Unternehmen | Position | Ende |
|---|---|---|
| PYXIS ONCOLOGY, INC. | Gründer | - |
| JOUNCE THERAPEUTICS, INC. | Gründer | - |
Ausbildung von Thomas F. Gajewski
| The University of Chicago | Doctorate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
| Börsennotierte Unternehmen | 1 |
|---|---|
| PYXIS ONCOLOGY, INC. | Health Technology |
| Private Unternehmen | 1 |
|---|---|
Jounce Therapeutics, Inc.
 Jounce Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Jounce Therapeutics, Inc. is a clinical stage immunotherapy company, which engages in developing treatments for cancer. It also provides novel cancer immunotherapies to attack tumors. The company was founded by Louis M. Weiner, Drew M. Pardoll, Thomas F. Gajewski, James P. Allison, Robert Schreiber, and Padmanee Sharma in 2013 and is headquartered in Cambridge, MA. | Commercial Services |
